Na. Darmani et al., The role of D-2 and D-3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew), J NEURAL TR, 106(11-12), 1999, pp. 1045-1061
This study introduces Cryptotis parva (the least shrew) as a new dopaminerg
ic animal model of emesis. The potential emetogenic effects of a nonselecti
ve dopamine agonist [apomorphine], two D-1 agonists [SKF-38393 and SKF-8295
8], a D-2 preferring agonist [quinpirole], and two D-3-preferring agonists
[7-(OH) DPAT and PD 128, 907] were investigated. Intraperitoneal administra
tion of D-1 agonists failed to induce emesis. However, other agonists cause
d a dose-dependent increase in the percentage of animals vomiting as well a
s potentiating the mean frequency of emesis with the following ED50 potency
order: 7-(OH) DPAT < apomorphine < quinpirole < PD 128, 907. For antagonis
t studies a 2 mg/kg dose of these agonists were used to induce emesis. Thus
, the inhibitory dose-response effects of a D-2-preferring [sulpride], a D-
3-preferring [U 99194A] and combination of varying doses of these antagonis
ts [sulpride + U 99194A] were evaluated on the ability of the cited agonist
s to produce vomiting. Sulpride decreased the number of shrews vomiting and
the mean vomiting frequency produced by the cited agonists in a dose-depen
dent fashion with the following ID50 order [apomorphine < PD 128, 907 < 7-(
OH) DPAT < quinpirole]. By itself, U 99194A failed to significantly alter t
he emesis produced by any of the cited agonists, however, it potentiated (3
-8 times) the antiemetic effects of sulpride both in reducing the number of
shrews vomiting as well as decreasing the mean vomiting frequency with the
following ID50 order: PD 128, 907 < 7-(OH) DPAT < quinpirole. However, U 9
9194A attenuated the potent antiemetic effect of sulpride on the apomorphin
e-induced emesis. The results suggest that the tested agonists primarily ac
tivate dopamine D-2 receptors to induce emesis in the least shrew whereas a
ctivation of D-3 sites potentiate the vomiting action of D-2 dopamine recep
tors.